1,272 results on '"Arbustini, Eloisa"'
Search Results
52. Apoptosis in Heart Failure: Release of Cytochrome c from Mitochondria and Activation of Caspase-3 in Human Cardiomyopathy
53. Air Pollution and Rupture of Abdominal Aortic Aneurysms
54. Prevalence and Complications of Aberrant Subclavian Artery in Patients With Heritable and Nonheritable Arteriopathies
55. Venous thromboembolism in hospitalized coronavirus disease 2019 patients stratified by vaccination status
56. Coronary 'microevagination' in intact fibrous cap acute coronary syndromes: another piece of the puzzle.
57. Ovarian cancer onset across differentBRCAmutation types: a view to a more tailored approach forBRCAmutated patients
58. Sex-specific features of optical coherence tomography detected plaque vulnerability related to clinical outcomes: insights from the CLIMA study
59. 42 SEASON VARIABILITY IN ATHEROSCLEROSIS COMPOSITION: INSIGHTS FROM 1848 NON-CULPRIT CORONARY PLQUES
60. Pathologic Findings at Risk Reducing Surgery in BRCA and Non-BRCA Mutation Carriers: A Single-Center Experience
61. Fifteen-Year Surveillance of LTR Receiving Pre-Emptive Therapy for CMV Infection: Prevention of CMV Disease and Incidence of CLAD
62. Genetics and clinics: together to diagnose cardiomyopathies
63. Intravenous thrombolysis before mechanical thrombectomy in patients with atrial fibrillation
64. Mechanical circulatory support in ventricular arrhythmias
65. Skating on thin ice: searching for vulnerable plaques
66. Impediments to Heart Transplantation in Adults With MELAS:m.3243A>G Cardiomyopathy
67. 2022-RA-1367-ESGO Clinical and survival data of early-stage tubo-ovarian carcinoma according to BRCA mutational status. A large, multicenter, retrospective study
68. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension Developed by the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Endorsed by the International Society for Heart and Lung Transplantation (ISHLT) and the European Reference Network on rare respiratory diseases (ERN-LUNG)
69. TCT-237 Clinical Effectiveness of Functional Assessment of Non-Culprit Coronary Lesions Using an Optical Coherence Tomography Computational Algorithm: A CLIMA Post-Hoc Analysis
70. Re: “The Impact of Degenerative Connective Tissue Disorders on Outcomes Following Endovascular Aortic Intervention in the Global Registry for Endovascular Aortic Treatment”
71. When you hear hoofbeats, think zebras – pulmonary veno‐occlusive disease: A case report
72. Translational Bioinformatics: Challenges and Opportunities for Case-Based Reasoning and Decision Support
73. The Pathologic Basis of Recovery
74. International External Validation Study of the 2014 European Society of Cardiology Guidelines on Sudden Cardiac Death Prevention in Hypertrophic Cardiomyopathy (EVIDENCE-HCM)
75. Anderson–Fabry disease
76. Contemporary genetic testing in inherited cardiac disease: tools, ethical issues, and clinical applications
77. The post‐DANISH era in clinical cardiology: Need of a better selection of patients for implantable cardioverter‐defibrillator in dilated cardiomyopathy
78. The atrial and ventricular myocardial proteome of end-stage lamin heart disease.
79. Optical coherence tomography-derived lipid core burden index and clinical outcomes: results from the CLIMA registry.
80. causes muscular dystrophy and arrhythmia by affecting protein trafficking
81. The MOGE(S) Classification for a Phenotype–Genotype Nomenclature of Cardiomyopathy: Endorsed by the World Heart Federation
82. Aortic root 3D parametric morphological model from 2D-echo images
83. Betaferon in chronic viral cardiomyopathy (BICC) trial: Effects of interferon-β treatment in patients with chronic viral cardiomyopathy
84. A targeted metabolomics assay for cardiac metabolism and demonstration using a mouse model of dilated cardiomyopathy
85. Optical coherence tomography-derived lipid core burden index and clinical outcomes: results from the CLIMA registry
86. Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy in Heart Transplantation: New Strategies and Preliminary Results in Endomyocardial Biopsies
87. Interpretation of genetic variants depends on a clinically guided integration of phenotype and molecular data
88. Monitoring of Inosine Monophosphate Dehydrogenase Activity and Expression during the Early Period of Mycophenolate Mofetil Therapy in De Novo Renal Transplant Patients
89. Evaluation of Oxidative Stress and Metabolic Profile in a Preclinical Kidney Transplantation Model According to Different Preservation Modalities
90. Role of Human Heart Mast Cells in Immunologic and Inflammatory Mechanisms Underlying Cardiovascular Disorders
91. Association between common cardiovascular risk factors and clinical phenotype in patients with hypertrophic cardiomyopathy from the European Society of Cardiology (ESC) EurObservational Research Programme (EORP) Cardiomyopathy/Myocarditis registry
92. Fatal ventricular arrhythmias in a young male with unrecognized LQT3 and cardiolaminopathy
93. ‘Precision and personalized medicine,’ a dream that comes true?
94. Ovarian cancer onset across different BRCA mutation types: a view to a more tailored approach for BRCA mutated patients.
95. A genetic variant alters the secondary structure of the lncRNA H19 and is associated with dilated cardiomyopathy.
96. “My Parents Died of Myocardial Infarction: Is that My Destiny?”
97. Interpretation and actionability of genetic variants in cardiomyopathies: a position statement from the European Society of Cardiology Council on cardiovascular genomics
98. Relationship betweeen the amount and location of macrophages and clinical outcome: subanalysis of the CLIMA-study
99. Cell density modulates SHC3 expression and survival of human glioblastoma cells through Fak activation
100. Prevention of no-reflow phenomenon in culprit lesions involving a large side branch
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.